Genesis Therapeutics
✓ Verified
Healthcare AI
Small molecule drug discovery
Series B
Genesis Therapeutics is an AI-focused biotechnology company that uses its proprietary GEMS (Genesis Exploration of Molecular Space) platform to discover and optimize small molecule medicines, with an emphasis on severe diseases and challenging drug targets. The company operates from Burlingame, California, with a laboratory in San Diego, and has pursued internal pipeline development as well as collaborations with major pharmaceutical companies.
Company Details
- Website
- genesistherapeutics.ai
- Headquarters
- Burlingame, California, United States
- Founded
- 2019
- Funding
- Over $300M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring